Essential Healthcare News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.

Press releases published on September 4, 2026

Sep. 4, 2026

Intellia Therapeutics Secures Non-Dilutive Debt Facility with OrbiMed for up to $400 Million

Indeterminate GlobeNewswire

Sep. 4, 2026

Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England

Indeterminate GlobeNewswire

Sep. 4, 2026

Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care

Indeterminate GlobeNewswire

Sep. 4, 2026

Akribis Veins & Vitality Highlights Non-Invasive Red Light Therapy for Chronic Pain Management

Indeterminate EIN Presswire

Sep. 4, 2026

East Africa’s digital health shift puts AI and hospital tech on procurement agenda at WHX in Nairobi

Indeterminate EIN Presswire

Sep. 4, 2026

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 4, 2026

Intellia Therapeutics to Present at Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 4, 2026

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 4, 2026

Iovance Biotherapeutics to Present at Upcoming Conferences

Indeterminate GlobeNewswire

Sep. 4, 2026

Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress

Indeterminate GlobeNewswire

Sep. 4, 2026

Alumis to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 4, 2026

Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms

Indeterminate GlobeNewswire

Sep. 4, 2026

Clearmind Medicine Signs Definitive Agreement to Acquire 51% Stake in Wireless Charging Company for Automated Parking and Robotaxis

Indeterminate GlobeNewswire

Sep. 4, 2026

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 4, 2026

Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences

Indeterminate GlobeNewswire

Sep. 4, 2026

VERAXA Biotech Appoints Raju Willener as Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 4, 2026

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

Indeterminate GlobeNewswire

Sep. 4, 2026

BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier

Indeterminate GlobeNewswire

Sep. 4, 2026

Immuron to launch PROIBS® in the United States

Indeterminate GlobeNewswire

Sep. 4, 2026

De Cape Town à Québec : Le passage du flambeau vers Safety 2028 est officiellement lancé

Indeterminate GlobeNewswire